Skip to content
People

Kevin L Eisenfrats

Chief Executive Officer at Contraline.

Earliest Form D on file: Jun 2026

Filed Jun 10, 2026

Contraline

Hydrogel implant for reversible male contraception

Biotech, Charlottesville VA

Signed as Chief Executive Officer

$55.8M

sold of $115.9M offered

Form D

LinkedIn

Network

At Contraline

4 people